May 24th Highlights

  • MDMA for PTSD - MDMA, the active ingredient in the party drug ecstasy, is being touted as a game-changing treatment for post-traumatic stress disorder. It is being trialed in America—and for one army veteran the drug has been a life-saver - this is a truly marvelous video 
  • EU is a cast cannabis landscape - The EU has a broad range of cannabis frameworks which operate some strictly, others the extreme opposite. Countries like Luxembourg are playing around with outlines for legalization on a recreational level. Other places already exist with interesting laws like the Netherlands with its infamous coffeeshops, Spain with its legal-through-a-loophole cannabis clubs which allow for localised smoking, and Denmark which actually has an entire enclave in the form of Freetown Christiania where drugs are sold (nearly) freely on the streets (of an otherwise strict country). Material sourced from this link
  • A stuy on chronic neuropathic pain -  The University of New Mexico conducted a study to understand the effects of hemp oil on chronic neuropathic pain. The report stated that using a chronic neuropathic pain model that exposes mice to postoperative neuropathic pain equivalent to several years of chronic pain in human clinical patients, the researchers were able to examine how hemp oil influences momentary pain sensitivity to the affected region. For several hours after Cannabis consumption the mice demonstrated effective pain relief, approaching the mechanical pain sensitivity of naïve control mice that did not undergo the surgical operation. Study reference

How MDMA is being used to treat PTSD | The Economist

Psychedelic drugs could help treat the mental health epidemic we'll face after coronavirus

Korean sovereign fund buys into cannabis as Canadian fund slashes Canopy stake

British cannabis producer Bridge Farm sold for £66m

MediPharm Labs Australia signs first European white-label cannabis supply agreement with UK-based Cannaray’s Therismos

Althea signs medicinal cannabis supply agreement with UK's Grow Pharma

THC Global releases first locally-made medicinal cannabidiol for Australian patients

New Zealanders reluctant to talk to their doctor about medicinal cannabis, study finds

Helius Group, is launching New Zealand’s first ever medicinal cannabis for pets’ product range